Flushed With Cash, Moderna Expands Space, Went on Hiring Spree and Launches at Least Two Clinical Trials
Abbott (ABT) Sales Rep in India Blames Company in Suicide Note
Boehringer Ingelheim Halts Two Phase III Trials for Lung Cancer Drug Gilotrif
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal
400+ Women are Suing Drug Giant Merck & Co. (MRK) Over Unequal Pay
Speculation Heats Up on Biogen (BIIB) as an Acquisition Target or Starting a Buying Spree
Clinton Running Mate Tim Kaine Scrutinized for Private Plane Ride Provided by Teva (TEVA) Subsidiary
Celgene (CELG)'s Revlimid Fails to Extend Survival in Lymphoma Study
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank
Genmab, Inc. (GEN.CO), Johnson & Johnson (JNJ)'s Daratumumab Granted Breakthrough Tag by the FDA
French-Based Firm Advanced Accelerator Applications Opens Up Shop in New Jersey, Plans to Hire
pSivida (PSDV) Has Its Own Brexit, Consolidates U.K. Operations to Massachusetts HQ
FDA Green Lights AbbVie (ABBV) Once-Daily Viekira XR for Hepatitis C
These Kinds Of Jobs Can Help Protect Your Brain From Alzheimer's, University of Wisconsin-Madison Study
Martin Shkreli’s Anti-Brunch Rant Reminds Us That Martin Shkreli Is Wrong About Many Things
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA)
Takeda (TKPYY) May Sell Some Non-Core Assets to Raise Cash
Bankrupt BIND Therapeutics (BIND) Reveals Two More Bidders Join Pfizer (PFE)'s Stalking Horse Bid
See All News >
//-->